Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals

被引:0
|
作者
Nirenberg, MJ
Chan, J
Liu, YJ
Edwards, RH
Pickel, VM
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143
[2] UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143
关键词
ultrastructure; dopamine; caudate-putamen; synaptic vesicle; densecore vesicle;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The vesicular monoamine transporter-2 (VMAT2) mediates the reserpine-sensitive neuronal uptake of monoamines into vesicles and other intracellular organelles. Accordingly, this transporter is expressed at high levels in regions that contain a dense monoamine innervation, such as the rat dorsolateral striatum. We used ultrastructural immunocytochemistry in this region to show that immunogold labeling for VMAT2 is present in varicose axonal processes, many of which also contain the catecholamine-synthesizing enzyme tyrosine-hydroxylase. Within these mainly dopaminergic processes, VMAT2 was associated with small synaptic vesicles (SSVs) and more rarely with large dense-core vesicles or tubulovesicles. These findings suggest that SSVs are the major organelles involved in the storage and release of dopamine in the dorsolateral striatum. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:194 / 198
页数:5
相关论文
共 50 条
  • [1] Variants of the primate vesicular monoamine transporter-2
    Jassen, AK
    Brown, JM
    Panas, HN
    Miller, GM
    Xiao, DQ
    Madras, BK
    MOLECULAR BRAIN RESEARCH, 2005, 139 (02): : 251 - 257
  • [2] TRANSPORT OF HISTAMINE BY VESICULAR MONOAMINE TRANSPORTER-2
    MERICKEL, A
    EDWARDS, RH
    NEUROPHARMACOLOGY, 1995, 34 (11) : 1543 - 1547
  • [3] The Effect of APOE ε4 on Striatal Vesicular Monoamine Transporter-2 Density in Parkinson's Disease
    Li, W.
    Li, R.
    Lu, J.
    MOVEMENT DISORDERS, 2023, 38 : S695 - S695
  • [4] Ephedrine Decreases Vesicular Monoamine Transporter-2 Function
    Ellis, Jonathan D.
    German, Christopher L.
    Birdsall, Elisabeth
    Hanson, Jarom E.
    Crosby, Marcus A.
    Rowley, Shane D.
    Sawada, Nicole A.
    West, Jeremiah N.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    SYNAPSE, 2011, 65 (05) : 449 - 451
  • [5] The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson's disease
    Li, W.
    Li, R.
    Lu, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 308 - 308
  • [6] Lobelane analogues as novel ligands for the vesicular monoamine transporter-2
    Zheng, GR
    Dwoskin, LP
    Deaciuc, AG
    Zhu, J
    Jones, MD
    Crooks, PA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (12) : 3899 - 3909
  • [7] Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine
    Riddle, EL
    Topham, MK
    Haycock, JW
    Hanson, GR
    Fleckenstein, AE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 449 (1-2) : 71 - 74
  • [8] Apomorphine increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 proteins
    Truong, JG
    Greene, MT
    Cook, GA
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2004, 18 (04): : A207 - A207
  • [9] Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake
    Rau, Kristi S.
    Birdsall, Elisabeth
    Volz, Trent J.
    Riordan, James A.
    Baucum, Anthony J., II
    Adair, Brian P.
    Bitter, Rebecca
    Gibb, James W.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02): : 676 - 682
  • [10] Synthesis and evaluation of a series of homologues of lobelane at the vesicular monoamine transporter-2
    Zheng, Guangrong
    Dwoskin, Linda P.
    Deaciuc, Agripina G.
    Crooks, Peter A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) : 6509 - 6512